Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis

• Autores principales: Pedro A. Ruiz Castro (Autor), Ulrike Kogel (Autor), Giuseppe Lo Sasso (Autor), Blaine W. Phillips (Autor), Alain Sewer (Autor), Bjorn Titz (Autor), Llenalia Garcia (Autor), Athanasios Kondylis (Autor), Emmanuel Guedj (Autor), Dariusz Peric (Autor), David Bornand (Autor), Remi Dulize (Autor), Celine Merg (Autor), Maica Corciulo (Autor), Nikolai V. Ivanov (Autor), Manuel C. Peitsch (Autor), Julia Hoeng (Autor)
• Formato: Libro
• Publicado: BMC, 2020-08-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Abstract Background Inflammatory bowel disease (IBD) is the collective term for chronic immune-mediated diseases of unknown, multifactorial etiology, arising from the interplay between genetic and environmental factors and including two main disease manifestations: ulcerative colitis (UC) and Crohn&...